research - vialsThis Faculty is committed to the development of excellence in health research. While its research priorities are determined by local and regional needs, its perspective remains international through the development of productive research collaborations with renowned research institutions across the world. In so doing, the Faculty of Medical Sciences brings developed world technology to solve regional health problems, as defined by regional governments and agencies.

Research Areas

: Medicinal Natural Products Research       : Neuroscience/Neurodegenerative Diseases
: Metabolic Syndrome & COPD Research     : Tropical Medicine Cluster: Infectious Diseases
: Restorative Dental Sciences                    : Child Dental Health/Dental Public Health


Recent Publications

Perioperative outcome of carotid endarterectomy with regional anesthesia: two decades of experience from the Caribbean
Regional anesthesia is a safe method for carotid endarterectomy in a limited-resources setting, as it facilitates intraoperative clinical assessment of the effects of internal carotid artery clamping.

Medical problems among dental patients at the School of Dentistry, the University of the West Indies
Hypertension (12.6 percent), diabetes (6.1 percent), asthma (5.8 percent), arthritis (4.7 percent), and various allergies (8.3 percent) constituted an important segment of the medical problems among new and consecutive dental patients. Gender, ethnic, and age differences were also evident for some diseases.

Isolation of enteric pathogens from bats in Trinidad.
Bats are one of the most widely distributed mammals in the world, and they are reservoirs or carriers of several zoonoses. Of 377 tested bats, four bats (1.1%) were positive for Samonella spp, 49 (13.0%) were positive for E. coli, and no bats were positive for E. coli O157 strain or Campylobacter spp. Of the 49 isolates of E. coli tested, 40 (82%) exhibited resistance to one or more antimicrobial agents, and the prevalence of resistant strains was comparatively high to erythromycin (61%) and streptomycin (27%), but lower to gentamycin (0%) and sulphamethozaxole/trimethoprim (2%).